Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

4.66
+0.16503.67%
Post-market: 4.63-0.0265-0.57%19:57 EDT
Volume:2.02M
Turnover:9.36M
Market Cap:584.60M
PE:-7.16
High:4.72
Open:4.54
Low:4.52
Close:4.50
52wk High:7.55
52wk Low:2.93
Shares:125.45M
Float Shares:115.00M
Volume Ratio:0.42
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6512
EPS(LYR):-0.7836
ROE:148.50%
ROA:-29.20%
PB:-10.33
PE(LYR):-5.95

Loading ...

Aquestive Therapeutics - Plans Anaphylm Nda Resubmission in Q3 2026

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics - Revised Instructions Reduce Incorrect Anaphylm Film Placement by over 80%

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

GlobeNewswire
·
Jul 29

Aquestive Therapeutics CEO Daniel Barber Disposes of 25,000 Common Shares Worth $100,201.97

Reuters
·
Jul 18

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire
·
Jul 07

Aquestive Therapeutics files to sell 230,271 shares of common stock for holders

TIPRANKS
·
Jun 27

Aquestive Therapeutics - Files Prospectus for Resale of up to 230,271 Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jun 27

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST), Revolution Medicines (RVMD) and Bolt Biotherapeutics (BOLT)

TIPRANKS
·
Jun 25

Aquestive Therapeutics Director Julie Krop Disposes of 25,000 Common Shares for $125,392.5

Reuters
·
Jun 24

Aquestive Therapeutics CEO Daniel Barber sells 25,000 shares for $104,010

Reuters
·
Jun 17

Aquestive Therapeutics holds annual shareholder meeting

Reuters
·
Jun 11

Aquestive CEO Daniel Barber disposes of 8,257 shares worth $35,406.44

Reuters
·
May 19

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

Aquestive Therapeutics (AQST) Q1 Loss Per Share Narrows Challenging Bearish Narratives

Simply Wall St.
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
May 15

Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility of up to $150 Mln on May 12, 2026 - SEC Filing

THOMSON REUTERS
·
May 14

Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income

Reuters
·
May 14

BRIEF-Aquestive Therapeutics, Inc. Q1 Revenue USD 14.446 Million Vs. IBES Estimate USD 10.9 Million

Reuters
·
May 14

Aquestive Therapeutics, Inc. Outlook FY Revenue USD 46-50 Million

THOMSON REUTERS
·
May 14